Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

Moon-Chang Choi, Seock‐Ah Im(Seoul National University), Jeffrey W. Streb(American Physiological Society), Ju‐Hee Lee(Dongguk University), Jung‐Hyun Park(National Cancer Institute), Sung-Hak Kim(Seoul National University), Yang-Ui Lee(Seoul National University), Hyun-Soon Jong, Do‐Youn Oh(Seoul National University Hospital), Tae-You Kim(Seoul National University)
The International Journal of Biochemistry & Cell Biology
January 1, 2008
10.1016/j.biocel.2008.04.020
Cited by 7

Related Papers

Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|The Lancet Oncology|2016|1.8k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
|The Lancet|2020|1.8k